Central neurocytoma

A novel appraisal of a polymorphic pathology - Our experience and a review of the literature

Jacopo Lenzi, Maurizio Salvati, Antonino Raco, Alessandro Frati, Manolo Piccirilli, Roberto Delfini

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Central neurocytoma should be considered in the differential diagnosis of intraventricular tumours. The records of 20 patients operated on between 1975 and 2000 for central neurocytoma were retrospectively reviewed, and the histological gradings and clinical outcomes were compared. On the basis of our previous cases, in the latter five of this series, the following therapeutic protocol was adopted. In those cases in which total removal was achieved, no further treatment was given if the MIB-1 index was 4%, a course of conformational radiotherapy was delivered. In subtotally removed cases, radiosurgery with linac was also performed (median dose 20 Gy) as well as conformational radiotherapy whenever there was a recurrence of the lesion (median dose 45 Gy). In cases in which there was only partial cytoreduction, conformational radiotherapy was administered with the adjunct of polychemotherapy if the MIB-1 was >4%. Twenty patients were surgically treated: 11 men and nine women, with an average age of 26 years (range 17 years to 42 years).Total, subtotal and partial removals were achieved in, respectively, ten, three and seven cases. At average follow-up of 7 years, 16 patients had been cured, had significantly improved or were at least stable [Karnofsky performance status score (KPS)] >70 or more)].On the other hand, four patients had worsened; of these, two had died and two had a KPS=50 and an unfavourable prognosis. The presence of histological atypia has proved to be a significantly negative risk factor for survival (P=0.02) while an MIB score >4% was significantly correlated with an unfavourable outcome (death or worsening of neurological status). The "atypical" neurocytoma seems to be a distinct entity, with a less favourable prognosis and a higher tendency to recur.

Original languageEnglish
Pages (from-to)286-292
Number of pages7
JournalNeurosurgical Review
Volume29
Issue number4
DOIs
Publication statusPublished - Oct 2006

Fingerprint

Neurocytoma
Pathology
Karnofsky Performance Status
Radiotherapy
Radiosurgery
Combination Drug Therapy
Differential Diagnosis
Recurrence
Survival
Therapeutics
Neoplasms

Keywords

  • Atypia
  • Central neurocytoma
  • Chemotherapy
  • Intraventricular tumours
  • Radiotherapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Central neurocytoma : A novel appraisal of a polymorphic pathology - Our experience and a review of the literature. / Lenzi, Jacopo; Salvati, Maurizio; Raco, Antonino; Frati, Alessandro; Piccirilli, Manolo; Delfini, Roberto.

In: Neurosurgical Review, Vol. 29, No. 4, 10.2006, p. 286-292.

Research output: Contribution to journalArticle

Lenzi, Jacopo ; Salvati, Maurizio ; Raco, Antonino ; Frati, Alessandro ; Piccirilli, Manolo ; Delfini, Roberto. / Central neurocytoma : A novel appraisal of a polymorphic pathology - Our experience and a review of the literature. In: Neurosurgical Review. 2006 ; Vol. 29, No. 4. pp. 286-292.
@article{d2867c74b49b4971893ae28da5191e6e,
title = "Central neurocytoma: A novel appraisal of a polymorphic pathology - Our experience and a review of the literature",
abstract = "Central neurocytoma should be considered in the differential diagnosis of intraventricular tumours. The records of 20 patients operated on between 1975 and 2000 for central neurocytoma were retrospectively reviewed, and the histological gradings and clinical outcomes were compared. On the basis of our previous cases, in the latter five of this series, the following therapeutic protocol was adopted. In those cases in which total removal was achieved, no further treatment was given if the MIB-1 index was 4{\%}, a course of conformational radiotherapy was delivered. In subtotally removed cases, radiosurgery with linac was also performed (median dose 20 Gy) as well as conformational radiotherapy whenever there was a recurrence of the lesion (median dose 45 Gy). In cases in which there was only partial cytoreduction, conformational radiotherapy was administered with the adjunct of polychemotherapy if the MIB-1 was >4{\%}. Twenty patients were surgically treated: 11 men and nine women, with an average age of 26 years (range 17 years to 42 years).Total, subtotal and partial removals were achieved in, respectively, ten, three and seven cases. At average follow-up of 7 years, 16 patients had been cured, had significantly improved or were at least stable [Karnofsky performance status score (KPS)] >70 or more)].On the other hand, four patients had worsened; of these, two had died and two had a KPS=50 and an unfavourable prognosis. The presence of histological atypia has proved to be a significantly negative risk factor for survival (P=0.02) while an MIB score >4{\%} was significantly correlated with an unfavourable outcome (death or worsening of neurological status). The {"}atypical{"} neurocytoma seems to be a distinct entity, with a less favourable prognosis and a higher tendency to recur.",
keywords = "Atypia, Central neurocytoma, Chemotherapy, Intraventricular tumours, Radiotherapy",
author = "Jacopo Lenzi and Maurizio Salvati and Antonino Raco and Alessandro Frati and Manolo Piccirilli and Roberto Delfini",
year = "2006",
month = "10",
doi = "10.1007/s10143-006-0024-x",
language = "English",
volume = "29",
pages = "286--292",
journal = "Neurosurgical Review",
issn = "0344-5607",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Central neurocytoma

T2 - A novel appraisal of a polymorphic pathology - Our experience and a review of the literature

AU - Lenzi, Jacopo

AU - Salvati, Maurizio

AU - Raco, Antonino

AU - Frati, Alessandro

AU - Piccirilli, Manolo

AU - Delfini, Roberto

PY - 2006/10

Y1 - 2006/10

N2 - Central neurocytoma should be considered in the differential diagnosis of intraventricular tumours. The records of 20 patients operated on between 1975 and 2000 for central neurocytoma were retrospectively reviewed, and the histological gradings and clinical outcomes were compared. On the basis of our previous cases, in the latter five of this series, the following therapeutic protocol was adopted. In those cases in which total removal was achieved, no further treatment was given if the MIB-1 index was 4%, a course of conformational radiotherapy was delivered. In subtotally removed cases, radiosurgery with linac was also performed (median dose 20 Gy) as well as conformational radiotherapy whenever there was a recurrence of the lesion (median dose 45 Gy). In cases in which there was only partial cytoreduction, conformational radiotherapy was administered with the adjunct of polychemotherapy if the MIB-1 was >4%. Twenty patients were surgically treated: 11 men and nine women, with an average age of 26 years (range 17 years to 42 years).Total, subtotal and partial removals were achieved in, respectively, ten, three and seven cases. At average follow-up of 7 years, 16 patients had been cured, had significantly improved or were at least stable [Karnofsky performance status score (KPS)] >70 or more)].On the other hand, four patients had worsened; of these, two had died and two had a KPS=50 and an unfavourable prognosis. The presence of histological atypia has proved to be a significantly negative risk factor for survival (P=0.02) while an MIB score >4% was significantly correlated with an unfavourable outcome (death or worsening of neurological status). The "atypical" neurocytoma seems to be a distinct entity, with a less favourable prognosis and a higher tendency to recur.

AB - Central neurocytoma should be considered in the differential diagnosis of intraventricular tumours. The records of 20 patients operated on between 1975 and 2000 for central neurocytoma were retrospectively reviewed, and the histological gradings and clinical outcomes were compared. On the basis of our previous cases, in the latter five of this series, the following therapeutic protocol was adopted. In those cases in which total removal was achieved, no further treatment was given if the MIB-1 index was 4%, a course of conformational radiotherapy was delivered. In subtotally removed cases, radiosurgery with linac was also performed (median dose 20 Gy) as well as conformational radiotherapy whenever there was a recurrence of the lesion (median dose 45 Gy). In cases in which there was only partial cytoreduction, conformational radiotherapy was administered with the adjunct of polychemotherapy if the MIB-1 was >4%. Twenty patients were surgically treated: 11 men and nine women, with an average age of 26 years (range 17 years to 42 years).Total, subtotal and partial removals were achieved in, respectively, ten, three and seven cases. At average follow-up of 7 years, 16 patients had been cured, had significantly improved or were at least stable [Karnofsky performance status score (KPS)] >70 or more)].On the other hand, four patients had worsened; of these, two had died and two had a KPS=50 and an unfavourable prognosis. The presence of histological atypia has proved to be a significantly negative risk factor for survival (P=0.02) while an MIB score >4% was significantly correlated with an unfavourable outcome (death or worsening of neurological status). The "atypical" neurocytoma seems to be a distinct entity, with a less favourable prognosis and a higher tendency to recur.

KW - Atypia

KW - Central neurocytoma

KW - Chemotherapy

KW - Intraventricular tumours

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=33748629679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748629679&partnerID=8YFLogxK

U2 - 10.1007/s10143-006-0024-x

DO - 10.1007/s10143-006-0024-x

M3 - Article

VL - 29

SP - 286

EP - 292

JO - Neurosurgical Review

JF - Neurosurgical Review

SN - 0344-5607

IS - 4

ER -